Fraxetin suppresses the proliferation, migration, and invasion of ovarian cancer cells by inhibiting the TLR4/STAT3 signaling pathway.

Xu, Ruhu; Ruan, Yingdan; Zhang, Lan; Gu, Yating; Liu, Mingming

Xu, Ruhu; Ruan, Yingdan; Zhang, Lan; Gu, Yating; Liu, Mingming.

Afiliação

Xu R; Department of Traditional Chinese Medicine, Taizhou First People's Hospital, Taizhou City, China.
Ruan Y; Department of Rehabilitation, Taizhou First People's Hospital, Taizhou City, China.
Zhang L; Department of Geriatrics, Taizhou First People's Hospital, Taizhou City, China.
Gu Y; Department of Traditional Chinese Medicine, Taizhou First People's Hospital, Taizhou City, China.
Liu M; Department of Traditional Chinese Medicine, Taizhou First People's Hospital, Taizhou City, China.

Immunopharmacol Immunotoxicol ; 45(3): 287-294, 2023 Jun.

Article em En | MEDLINE | ID: mdl-36346016

Assuntos

Neoplasias Ovarianas; Receptor 4 Toll-Like; Humanos; Feminino; Receptor 4 Toll-Like/metabolismo; Linhagem Celular Tumoral; Proliferação de Células; Movimento Celular; Transdução de Sinais; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/patologia; Fator de Transcrição STAT3/metabolismo; Transição Epitelial-Mesenquimal

Palavras-chave

Epithelial-to-mesenchymal transition; Fraxetin; TLR4/STAT3 signaling pathway; ovarian cancer; traditional Chinese medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptor 4 Toll-Like Limite: Female / Humans Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google